Immunohistological Analysis of ABCD3 Expression in Caucasian and African American Prostate Tumors

by R. Renee Reams, Jacqueline Jones-Triche, Owen T. M. Chan, Brenda Y. Hernandez, Karam F. A. Soliman, Clayton Yates
Published 2015-01-01

Sphingosine kinase 1 expression enhances colon tumor growth

by Hideki Furuya, Yoshiko Shimizu, Paulette M. Tamashiro, Kayoko Iino, Jacek Bielawski, Owen T. M. Chan, Ian Pagano, Toshihiko Kawamori
Published 2017-06-01

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [18F]fluorocholine PET/CT

by Sandi A. Kwee, Linda L. Wong, Brenda Y. Hernandez, Owen T.M. Chan, Miles M. Sato, Naoky Tsai
Published 2015-05-01

Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer

by Charles J. Rosser, Sergei Tikhonenkov, Jeffrey W. Nix, Owen T.M. Chan, Irina Ianculescu, Sandeep Reddy, Patrick Soon-Shiong
Published 2021-01-01

Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model

by Hideki Furuya, Owen T. M. Chan, Ian Pagano, Chengjun Zhu, Nari Kim, Rafael Peres, Kanani Hokutan, Sarah Alter, Peter Rhode, Charles J. Rosser
Published 2019-01-01

Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma

by Hideki Furuya, Owen T.M. Chan, Kanani Hokutan, Yutaro Tsukikawa, Keanu Chee, Landon Kozai, Keith S. Chan, Yunfeng Dai, Regan S. Wong, Charles J. Rosser
Published 2019-12-01

Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder canc...

by Hideki Furuya, Kazukuni Hayashi, Yoshiko Shimizu, Nari Kim, Yutaro Tsukikawa, Runpu Chen, Yijun Sun, Owen T. M. Chan, Ian Pagano, Rafael Peres, Kanani Hokutan, Fumie Igari, Keith S. Chan, Charles J. Rosser
Published 2020-02-01

Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T

by Jeffrey Huang, Sumanta Pal, Tanya Dorff, Owen T M Chan, Hideki Furuya, Ian Pagano, Yosuke Hirasawa, Jared Acoba, David Tamura, Minlu Zhang, Rebecca Waitz, Abhilash Dhal, Winston Haynes, John Shon, Mark Scholz, Charles Rosser
Published 2021-08-01